Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Dr Agarwals Eye Hsp
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Dr Agarwals Eye Hsp

WEBSITE BSE:526783 NSE: DR.AGAR.EYE Inc. Year: 1994 Industry: Hospital & Healthcare Services My Bucket: Add Stock

₹5004.5 128.6 | 2.6%

Last updated: 15:54

Consolidated Standalone

Last updated: 15:54

Dr Agarwals Eye Hsp Overview

Dr. Agarwal's Eye Hospital Ltd is an eye care organisation. The Company is engaged in supplying clinic and health-associated offerings. The Company additionally affords nursing homes; clinics; clinical, studies and different institutions and institutions for eye care and treatment, and different healthcare facilities. The Company is likewise engaged in hospital-related trading and different activities. The Company gives offerings associated with cataract, glaucoma, laser correction, cornea and refractive, retina, squint, pediatric ophthalmology...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Dr Agarwals Eye Hsp Key Financials

Market Cap ₹2419 Cr.

Stock P/E 44.3

P/B 7.3

Current Price ₹5004.5

Book Value ₹ 686.7

Face Value 10

52W High ₹6392

Dividend Yield 0.12%

52W Low ₹ 3866.9

Edit Ratio

Dr Agarwals Eye Hsp Share Price

₹ | |

Volume
Price

Dr Agarwals Eye Hsp Quarterly Price

Quarterly Monthly
Show Value Show %

Dr Agarwals Eye Hsp Peer Comparison

Dr Agarwals Eye Hsp Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 84 76 81 100 102 95 100 117 118 116
Other Income 1 1 2 0 2 2 0 1 1 3
Total Income 86 77 83 100 104 97 100 118 118 119
Total Expenditure 61 55 56 69 72 69 68 80 78 82
Operating Profit 25 21 27 32 32 28 32 38 41 37
Interest 2 2 2 3 4 4 3 4 4 2
Depreciation 6 7 8 10 9 10 10 11 11 12
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 17 13 17 19 19 14 19 23 26 23
Provision for Tax 4 3 5 5 5 4 3 6 6 6
Profit After Tax 13 9 13 14 14 10 16 17 19 17
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 13 9 13 14 14 10 16 17 19 17
Adjusted Earnings Per Share 26.8 20.1 27.2 30 30.1 22.1 34 36.7 40 35.8

Dr Agarwals Eye Hsp Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 118 137 149 153 170 176 140 201 268 319 397 451
Other Income 0 0 2 2 2 3 2 1 2 5 6 5
Total Income 118 137 150 156 172 179 142 202 270 324 403 455
Total Expenditure 103 124 126 129 140 129 110 143 192 227 278 308
Operating Profit 15 13 24 27 32 50 32 60 78 97 125 148
Interest 4 5 4 3 4 9 7 7 8 8 15 13
Depreciation 6 9 9 10 11 21 19 20 20 27 39 44
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 5 -0 11 13 17 20 6 32 49 62 71 91
Provision for Tax -0 -1 4 7 6 6 7 8 12 16 16 21
Profit After Tax 6 0 7 7 12 14 -1 24 37 46 55 69
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 6 0 7 7 12 14 -1 24 37 46 55 69
Adjusted Earnings Per Share 12.1 0.1 15.6 14.4 25.4 29.1 -3.1 51.3 78.6 98.6 116.3 146.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 24% 25% 18% 13%
Operating Profit CAGR 29% 28% 20% 24%
PAT CAGR 20% 32% 31% 25%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 14% 63% 73% 40%
ROE Average 30% 34% 27% 24%
ROCE Average 33% 38% 35% 30%

Dr Agarwals Eye Hsp Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 24 23 29 35 46 56 55 78 113 157 210
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 15 18 13 5 13 8 10 21 36 44 82
Other Non-Current Liabilities -2 7 11 19 27 62 32 152 217 203 299
Total Current Liabilities 31 36 27 37 35 39 70 82 55 136 87
Total Liabilities 67 84 81 96 120 166 167 333 422 541 677
Fixed Assets 26 34 33 36 55 94 96 214 260 316 393
Other Non-Current Assets 18 27 28 37 36 43 6 69 115 110 228
Total Current Assets 23 24 20 23 30 30 66 50 47 115 56
Total Assets 67 84 81 96 120 166 167 333 422 541 677

Dr Agarwals Eye Hsp Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 1 2 2 2 4 6 22 28 27 33
Cash Flow from Operating Activities 14 17 20 19 25 39 34 57 70 90 94
Cash Flow from Investing Activities -10 -17 -8 -11 -25 -17 -11 -46 -71 -70 -133
Cash Flow from Financing Activities -5 -0 -12 -8 2 -20 -8 -4 0 -14 17
Net Cash Inflow / Outflow -1 0 0 -0 2 2 15 7 -1 6 -22
Closing Cash & Cash Equivalent 1 2 2 2 4 6 22 28 27 33 11

Dr Agarwals Eye Hsp Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 12.12 0.08 15.61 14.42 25.35 29.11 -3.06 51.28 78.55 98.64 116.28
CEPS(Rs) 25.22 18.22 34.21 35.23 48.57 74.29 37.58 94.66 121.49 155.26 200.21
DPS(Rs) 1.2 0.8 1.5 1.2 1.5 0 0 3 3 5 6
Book NAV/Share(Rs) 50.55 49.83 62.56 74.59 97 119.36 116.3 166.32 241.15 334.36 445.98
Core EBITDA Margin(%) 12.8 9.01 14.96 15.82 17.63 26.78 21.35 29.15 28.27 28.81 30.01
EBIT Margin(%) 7.78 2.97 10.19 10.94 12.37 16.21 9.08 19.64 21.42 22.1 21.54
Pre Tax Margin(%) 4.54 -0.35 7.39 8.71 10.25 11.33 4.1 16.06 18.43 19.5 17.8
PAT Margin (%) 4.82 0.03 4.94 4.42 7.01 7.78 -1.03 11.98 13.77 14.52 13.76
Cash Profit Margin (%) 10.03 6.27 10.83 10.8 13.42 19.85 12.63 22.11 21.3 22.85 23.69
ROA(%) 8.53 0.05 8.87 7.65 11.01 9.55 -0.86 9.63 9.78 9.63 8.97
ROE(%) 26.67 0.16 27.78 21.02 29.55 26.91 -2.6 36.29 38.56 34.28 29.8
ROCE(%) 18.81 7.7 28.26 31.7 34.3 39.87 16.92 42.4 42.98 38.59 33.26
Receivable days 18.4 20.21 19.29 16.31 16.86 15.98 20.3 15.83 12.78 13.17 12.36
Inventory Days 28.09 27.06 19.65 16.02 14.84 15.01 17.22 9.93 7.98 9 10.64
Payable days 172.41 184.21 167.01 170.63 159.39 131.47 175.92 170.19 156.75 151.41 126.34
PER(x) 10.31 2496.8 19.21 41.61 14.33 6.56 0 14.26 11.65 31.46 34.85
Price/Book(x) 2.47 3.91 4.8 8.04 3.75 1.6 2.69 4.39 3.8 9.28 9.09
Dividend Yield(%) 0.96 0.41 0.5 0.2 0.41 0 0 0.41 0.33 0.16 0.15
EV/Net Sales(x) 0.71 0.88 1.09 1.94 1.12 0.57 1.05 1.72 1.66 4.62 5.01
EV/Core EBITDA(x) 5.47 9.57 6.75 11.22 5.94 2.02 4.61 5.79 5.74 15.19 15.91
Net Sales Growth(%) 4.88 15.58 8.78 3.22 10.91 3.47 -20.54 43.92 33.24 19.1 24.38
EBIT Growth(%) 22.02 -55.83 272.71 10.8 25.49 35.59 -55.51 211.36 45.34 22.82 21.25
PAT Growth(%) 134.42 -99.36 0 -7.67 75.87 14.84 -110.51 1775.24 53.2 25.57 17.88
EPS Growth(%) 134.42 -99.36 0 -7.67 75.87 14.84 -110.51 1775.21 53.2 25.57 17.88
Debt/Equity(x) 1.14 1.33 0.78 0.52 0.52 0.31 0.4 0.41 0.39 0.33 0.46
Current Ratio(x) 0.74 0.66 0.73 0.62 0.84 0.75 0.94 0.61 0.85 0.85 0.64
Quick Ratio(x) 0.4 0.38 0.5 0.42 0.66 0.55 0.86 0.54 0.74 0.77 0.49
Interest Cover(x) 2.4 0.89 3.64 4.92 5.82 3.32 1.82 5.48 7.14 8.5 5.76
Total Debt/Mcap(x) 0.46 0.34 0.16 0.06 0.14 0.2 0.15 0.09 0.1 0.04 0.05

Dr Agarwals Eye Hsp Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 71.9 71.9 71.9 71.9 71.9 71.9 71.9 72.67 72.67 72.67
FII 0.63 0.64 0.65 0.83 0.84 1.33 1.5 1.74 1.82 2.2
DII 0 0 0 0.96 1.03 1.95 2.31 2.36 2.36 2.12
Public 27.47 27.46 27.46 26.31 26.23 24.83 24.29 23.23 23.15 23
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Dr Agarwals Eye Hsp News

Dr Agarwals Eye Hsp Pros & Cons

Pros

  • Company has delivered good profit growth of 31% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 34%
  • Debtor days have improved from 151.41 to 126.34days.
  • Company is almost debt free.

Cons

  • Stock is trading at 7.3 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!